Page last updated: 2024-11-11

jmv 390-1

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

JMV 390-1: a metallopeptidase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5487524
SCHEMBL ID13039995
MeSH IDM0210090

Synonyms (17)

Synonym
n-((2r)-4-(hydroxyamino)-1,4-dioxo-2-(phenylmethyl)butyl)-l-isoleucyl-l-leucine
jmv-390-1
l-leucine, n-(n-(4-(hydroxyamino)-1,4-dioxo-2-(phenylmethyl)butyl)-l-isoleucyl)-, (r)-
n-[(2r)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-l-isoleucyl-l-leucine
148473-36-3
jmv 390-1
l-leucine, n-((2r)-4-(hydroxyamino)-1,4-dioxo-2-(phenylmethyl)butyl)-l-isoleucyl-
(2s)-2-[[(2s,3s)-2-[[(2r)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid
l-leucine,n-[(2r)-4-(hydroxyamino)-1,4-dioxo-2-(phenylmethyl)butyl]-l-isoleucyl-
SCHEMBL13039995
n-[(2r)-4-hydroxyamino)-1,4-dioxo-2-(phenylmethyl)butyl]-l-isoleucyl-l-leucine
AKOS024457177
DTXSID70163994
n-[(2r)-4-(hydroxyamino)-1,4-dioxo-2-(phenylmethyl)butyl]-l-isoleucyl-l-leucine
HY-107761
CS-0029493
PD070442
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]